[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Johnson & Johnson (JNJ)

Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Johnson & Johnson Announces FDA Approval for the Dual Energy THERMOCOOL SMARTTOUCH SF Platform

Dual Energy THERMOCOOL SMARTTOUCH SF Platform brings pulse field and radiofrequency energy together in a single catheter. ...

JNJ : 260.46 (-1.12%)
Unusual Put Option Activity in Johnson & Johnson After JNJ Stock's Recent Runup

Today, there has been large and unusual put option activity in Johnson & Johnson (JNJ) after the stock's recent rise. The puts are out-of-the-money (OTM), implying that some investors believe JNJ could...

JNJ : 260.46 (-1.12%)
Only 3 Under-the-Radar Dividend Stocks Survived This Brutal Screen. One Could Rally 115%.

Three under-the-radar dividend stocks with solid returns, low debt and room to grow.

FFBC : 33.96 (+1.80%)
KO : 82.63 (-0.92%)
JNJ : 260.46 (-1.12%)
HLNE : 80.33 (+1.74%)
RDN : 37.58 (+0.24%)
These 3 Dividend Stocks Could Boost Your Income This July

Realty Income, Johnson & Johnson, and Chevron offer yields ranging from 2.2% to 5.1% in July 2026, supported by analyst buy ratings and institutional accumulation.

CVX : 174.38 (-0.90%)
JNJ : 260.46 (-1.12%)
O : 63.31 (+0.13%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 6.16 (-1.12%)
CMPS : 13.62 (-2.51%)
GHRS : 26.83 (-0.07%)
JNJ : 260.46 (-1.12%)
DFTX : 48.03 (+5.98%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 6.16 (-1.12%)
CMPS : 13.62 (-2.51%)
GHRS : 26.83 (-0.07%)
JNJ : 260.46 (-1.12%)
DFTX : 48.03 (+5.98%)
Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

GENEVA , June 26, 2026 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight...

JNJ : 260.46 (-1.12%)
Blackberry Stock Just Scored a New 'Buy' Rating. Here's Why.

Blackberry stock rallies as Stifel announces a bullish $12 price target. Here’s why the investment firm recommends owning BB shares at current levels.

BB : 11.54 (+3.78%)
NVDA : 202.22 (-0.93%)
QCOM : 192.72 (+3.30%)
JNJ : 260.46 (-1.12%)
AMD : 552.98 (+6.87%)
Johnson & Johnson Earnings Preview: What to Expect

Johnson & Johnson is scheduled to report its second-quarter results next month, and analysts expect a single-digit earnings rise.

XLV : 161.70 (-0.37%)
$SPX : 7,531.04 (+0.65%)
JNJ : 260.46 (-1.12%)
The $11 Billion Reason Abbvie Stock Is Up Today

AbbVie stock rallied today on the $10.9 billion acquisition of Apogee Therapeutics. Here’s how you should play ABBV shares at current levels.

APGE : 133.35 (+0.08%)
JNJ : 260.46 (-1.12%)
LLY : 1,203.92 (-0.98%)
ABBV : 251.06 (-0.66%)
REGN : 664.96 (+0.31%)
SNY : 43.70 (+2.15%)

Barchart Exclusives

PepsiCo's Quarterly Results Beat Expectations. PEP Stock Is Falling Anyway.
PepsiCo stock sinks despite market-beating Q2 earnings. But should you buy the dip in PEP shares today? Let’s find out! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.